Neurosurgical Unit, Saint Anna and Saint Sebastian Hospital of Caserta, Caserta, Italy.
Neurosurgical Unit, Saint Anna and Saint Sebastian Hospital of Caserta, Caserta, Italy.
World Neurosurg. 2021 Jan;145:370-375. doi: 10.1016/j.wneu.2020.08.148. Epub 2020 Aug 27.
Primary central nervous system sarcomas are rare primitive mesenchymal non-meningothelial tumors. Malignant peripheral nerve sheath tumor accounts for 5% of sarcomas, with an incidence of approximately 0.001% and a recognized association with neurofibromatosis type 1. Its intracranial subtype, the so-called malignant intracerebral nerve sheath tumor (MINST), is even more infrequent. Current knowledge about its clinical presentation and best therapeutic management is poor because of the limited number of cases reported in literature. Commonly, intratumoral hemorrhage occurs at the time of diagnosis and, notably, most patients had intracranial hemorrhage prior to definitive diagnosis.
We report a case of MINST in a young boy affected by neurofibromatosis type 1 who presented a spontaneous intracranial hemorrhage, successfully treated with surgery and postoperative adjuvant therapy. The tumor relapsed 1 year after and was successfully retreated with a second surgery.
Malignant intracerebral nerve sheath tumors are rare sarcomas that can be associated with intratumoral hemorrhage at the time of presentation, mostly in patients with neurofibromatosis type 1. Surgery promptly performed, associated with adjuvant therapy, can result in an encouraging survival rate.
原发性中枢神经系统肉瘤是罕见的原始间叶非脑膜内皮肿瘤。恶性外周神经鞘瘤占肉瘤的 5%,发病率约为 0.001%,并与神经纤维瘤病 1 型有明确的相关性。其颅内亚型,即所谓的恶性颅内神经鞘瘤(MINST)更为罕见。由于文献报道的病例数量有限,目前对其临床表现和最佳治疗管理的了解有限。通常,在诊断时会发生肿瘤内出血,值得注意的是,大多数患者在明确诊断前就已经发生了颅内出血。
我们报告了一例 1 型神经纤维瘤病患者发生的 MINST,该患者表现为自发性颅内出血,经手术和术后辅助治疗成功治疗。肿瘤在 1 年后复发,并成功接受了第二次手术治疗。
恶性颅内神经鞘瘤是罕见的肉瘤,可在出现时伴有肿瘤内出血,主要发生在神经纤维瘤病 1 型患者中。及时进行手术,并辅助辅助治疗,可以获得令人鼓舞的生存率。